Is omeprazole contraindicated in patients with hemophilia?

Omeprazole is NOT contraindicated in hemophilia

Omeprazole is not only safe but actually recommended as protective therapy for patients with hemophilia who require NSAIDs or antiplatelet agents. There is no contraindication listed in the FDA drug label for hemophilia, and clinical practice supports its use in this population 1.

Key Evidence

FDA Drug Label Review

The FDA-approved omeprazole prescribing information lists specific contraindications that do not include hemophilia 1:

• Known hypersensitivity reactions (anaphylaxis, angioedema, bronchospasm)
• Concurrent use with rilpivirine-containing products
• Acute tubulointerstitial nephritis (as a warning, not absolute contraindication)

Clinical Practice Guidance

When patients with hemophilia require NSAIDs for hemophilic arthropathy management, proton pump inhibitors like omeprazole are specifically recommended 2. The rationale is straightforward:

• Patients with hemophilia have an inherently higher risk of gastrointestinal bleeding compared to the general population
• NSAIDs (both traditional and COX-2 selective) increase upper GI bleeding risk
• COX-2 inhibitors should be used at the lowest dose for the shortest duration together with a proton pump inhibitor in hemophilia patients 2

Clinical Algorithm for Omeprazole Use in Hemophilia

When considering omeprazole in hemophilia patients:

1. Test for and eradicate Helicobacter pylori before starting any NSAID therapy (which would be covered by omeprazole) 2

2. Use omeprazole as gastroprotection when NSAIDs or antiplatelet agents are medically necessary 2

3. Monitor appropriately - while omeprazole itself doesn't require special monitoring in hemophilia, be aware of standard PPI warnings:

   • Bone fracture risk with long-term high-dose use 1
   • C. difficile-associated diarrhea risk 1
   • Acute tubulointerstitial nephritis (rare) 1

Important Caveats

The only hemophilia-relevant consideration is that omeprazole does not increase bleeding risk - in fact, it reduces GI bleeding risk when patients require medications that do increase bleeding 2. The standard PPI warnings about lupus erythematosus, kidney injury, and bone fractures apply equally to hemophilia patients as to the general population 1, but these are not contraindications.

Bottom line: Omeprazole should be used liberally in hemophilia patients requiring gastroprotection, particularly when NSAIDs or antiplatelet therapy is indicated.